151 related articles for article (PubMed ID: 33932829)
1. Implication of a lysosomal antigen in the pathogenesis of lupus erythematosus.
Wilhelm M; Bonam SR; Schall N; Bendorius M; Korganow AS; Lumbroso C; Muller S
J Autoimmun; 2021 Jun; 120():102633. PubMed ID: 33932829
[TBL] [Abstract][Full Text] [Related]
2. Modulation of deregulated chaperone-mediated autophagy by a phosphopeptide.
Macri C; Wang F; Tasset I; Schall N; Page N; Briand JP; Cuervo AM; Muller S
Autophagy; 2015; 11(3):472-86. PubMed ID: 25719862
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Remodeling of Altered Autophagy-Lysosomal Pathway by a Phosphopeptide in Lupus.
Wang F; Tasset I; Cuervo AM; Muller S
Cells; 2020 Oct; 9(10):. PubMed ID: 33092174
[TBL] [Abstract][Full Text] [Related]
4. LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles.
Qiao L; Hu J; Qiu X; Wang C; Peng J; Zhang C; Zhang M; Lu H; Chen W
Autophagy; 2023 Nov; 19(11):2837-2852. PubMed ID: 37469132
[TBL] [Abstract][Full Text] [Related]
5. AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.
White CA; Seth Hawkins J; Pone EJ; Yu ES; Al-Qahtani A; Mai T; Zan H; Casali P
Autoimmunity; 2011 Dec; 44(8):585-98. PubMed ID: 21585311
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody therapy that targets phospholipid-binding protein delays lupus activity in MRL/lpr mice.
Mihaylova N; Bradyanova S; Chipinski P; Chausheva S; Kyurkchiev D; Tchorbanov AI
Scand J Immunol; 2020 Sep; 92(3):e12915. PubMed ID: 32533866
[TBL] [Abstract][Full Text] [Related]
7. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
Front Immunol; 2020; 11():1047. PubMed ID: 32625200
[TBL] [Abstract][Full Text] [Related]
8. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice.
Monneaux F; Dumortier H; Steiner G; Briand JP; Muller S
Int Immunol; 2001 Sep; 13(9):1155-63. PubMed ID: 11526096
[TBL] [Abstract][Full Text] [Related]
9. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
10. T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice.
Suh CH; Freed JH; Cohen PL
J Immunol; 2003 Feb; 170(4):2229-35. PubMed ID: 12574397
[TBL] [Abstract][Full Text] [Related]
11. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
[TBL] [Abstract][Full Text] [Related]
12. Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development.
Wang M; Chen H; Qiu J; Yang HX; Zhang CY; Fei YY; Zhao LD; Zhou JX; Wang L; Wu QJ; Zhou YZ; Zhang W; Zhang FC; Zhang X; Lipsky PE
J Autoimmun; 2020 May; 109():102440. PubMed ID: 32201226
[TBL] [Abstract][Full Text] [Related]
13. Dependence on Autophagy for Autoreactive Memory B Cells in the Development of Pristane-Induced Lupus.
Jang A; Sharp R; Wang JM; Feng Y; Wang J; Chen M
Front Immunol; 2021; 12():701066. PubMed ID: 34335611
[TBL] [Abstract][Full Text] [Related]
14. A therapeutic peptide in lupus alters autophagic processes and stability of MHCII molecules in MRL/lpr B cells.
Page N; Gros F; Schall N; Briand JP; Muller S
Autophagy; 2011 May; 7(5):539-40. PubMed ID: 21282971
[TBL] [Abstract][Full Text] [Related]
15. Intermittent Fasting Aggravates Lupus Nephritis through Increasing Survival and Autophagy of Antibody Secreting Cells in MRL/lpr Mice.
Hong SM; Lee J; Jang SG; Song Y; Kim M; Lee J; Cho ML; Kwok SK; Park SH
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187196
[TBL] [Abstract][Full Text] [Related]
16. Parallel sets of autoantibodies in MRL-lpr/lpr mice. An anti-DNA, anti-SmRNP, anti-gp70 network.
Migliorini P; Ardman B; Kaburaki J; Schwartz RS
J Exp Med; 1987 Feb; 165(2):483-99. PubMed ID: 2950197
[TBL] [Abstract][Full Text] [Related]
17. Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity.
Pollard KM; Pearson DL; Hultman P; Hildebrandt B; Kono DH
Environ Health Perspect; 1999 Oct; 107 Suppl 5(Suppl 5):729-35. PubMed ID: 10502538
[TBL] [Abstract][Full Text] [Related]
18. Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2.
Yasuda K; Watkins AA; Kochar GS; Wilson GE; Laskow B; Richez C; Bonegio RG; Rifkin IR
PLoS One; 2014; 9(7):e103478. PubMed ID: 25076492
[TBL] [Abstract][Full Text] [Related]
19. The central and multiple roles of B cells in lupus pathogenesis.
Chan OT; Madaio MP; Shlomchik MJ
Immunol Rev; 1999 Jun; 169():107-21. PubMed ID: 10450512
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha-inducible proteins are novel autoantigens in murine lupus.
Hueber W; Zeng D; Strober S; Utz PJ
Arthritis Rheum; 2004 Oct; 50(10):3239-49. PubMed ID: 15476221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
